NCT04757766View on ClinicalTrials.gov

VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Chronic Venous Insufficiency
Interventions
DRUG

in daily everyday routine practice

The treatment of patients with chronic venous disease of CEAP classes C6 will be consistent with routine clinical practice, local label for the medical use of drugs and the specific clinical situation.

Trial Locations (1)

Unknown

The first Phlebological Center, Moscow

All Listed Sponsors
lead

Servier Russia

INDUSTRY

NCT04757766 - VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6) | Biotech Hunter | Biotech Hunter